{"id":65693,"date":"2022-12-30T11:39:21","date_gmt":"2022-12-30T09:39:21","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=65693"},"modified":"2023-10-09T10:47:36","modified_gmt":"2023-10-09T10:47:36","slug":"nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/","title":{"rendered":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d"},"content":{"rendered":"\n

El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong>, juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)<\/strong>, va organitzar una noa edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d<\/strong>, amb el patrocini de Bristol-Myers Squibb<\/a> <\/strong>i J<\/a>anssen<\/a>. <\/strong>L\u2019activitat va constar de cinc sessions que van realitzar experts de refer\u00e8ncia <\/strong>en cadascun dels c\u00e0ncers hematol\u00f2gics que es van tractar. Les sessions van ser coordinades pel vocal d\u2019Hospitals del COFB, David Conde<\/strong>, i es van adre\u00e7ar als farmac\u00e8utics hospitalaris.<\/strong><\/p>\n\n\n\n

\"Primera<\/a>
Primera fila, d\u2019esquerra a dreta: el Dr. Juan Manuel Sancho i el Dr. Carlos Fern\u00e1ndez. Segona fila, d\u2019esquerra a dreta: el Dr. Albert Alt\u00e9s i el Dr. Albert Oriol Rocafiguera.<\/figcaption><\/figure>\n\n\n\n

Els objectius <\/strong>del curs van ser actualitzar la gesti\u00f3 i el tractament dels diferents c\u00e0ncers hematol\u00f2gics<\/strong>, posar al dia els aspectes relacionats amb l\u2019atenci\u00f3 farmac\u00e8utica en la dispensaci\u00f3 de tractaments<\/strong> per combatre aquests c\u00e0ncers i con\u00e8ixer les necessitats dels pacients <\/strong>per oferir el suport emocional <\/strong>correcte.<\/p>\n\n\n\n

Actualitzaci\u00f3 en el tractament dels c\u00e0ncers hematol\u00f2gics<\/strong><\/h2>\n\n\n\n

Al llarg del curs formatiu, professionals de diferents \u00e0mbits de la medicina van repassar alguns tipus de c\u00e0ncers hematol\u00f2gics<\/strong> i els tractaments associats<\/strong> a cadascun d\u2019ells. El vocal d\u2019Hospitals del COFB, David Conde<\/strong>, va fer un breu resum del que es va comentar en les sessions. <\/p>\n\n\n\n

Limfoma de c\u00e8l\u00b7lules del mantell<\/strong><\/h3>\n\n\n\n

En la primera sessi\u00f3, del passat 3 de novembre, el cap assistencial del Servei d\u2019Hematologia Cl\u00ednica de l\u2019ICO Badalona de l\u2019Hospital Universitari Germans Trias i Pujol, el Dr. Juan Manuel Sancho<\/strong>, va revisar el limfoma de c\u00e8l\u00b7lules del mantell<\/strong>. El Dr. Sancho va exposar quines s\u00f3n les opcions de tractament actuals i futures<\/strong> d’aquesta patologia, que est\u00e0 sent molt investigada, i que en l’actualitat hi ha noves dianes per canviar el pron\u00f2stic <\/strong>amb millor perfil d\u2019efectes secundaris. En primera l\u00ednia, s\u2019incorporen els inhibidors BTK<\/strong> arribant a tenir esquemes chemo-free. En recaiguda, la ter\u00e0pia cel\u00b7lular<\/strong> t\u00e9 molta evid\u00e8ncia a l\u2019espera de finan\u00e7ament pel SNS.<\/p>\n\n\n\n

Malaltia de Waldenstr\u00f6m<\/strong><\/h3>\n\n\n\n

A continuaci\u00f3, el consultor del Servei d\u2019Hematologia de l\u2019Hospital Cl\u00ednic de Barcelona, el Dr. Carlos Fern\u00e1ndez<\/strong>, va parlar sobre la malaltia<\/strong> de Waldenstr\u00f6m<\/strong>. Es tracta d\u2019una patologia menys freq\u00fcent, per\u00f2 important, on els inhibidors de la tirosina de Bruton<\/strong> han esdevingut una incorporaci\u00f3 important d’arsenal terap\u00e8utic<\/strong>. En la xerrada es va comentar que queda explorar combinacions en recaiguda<\/strong> com el venetoclax o altres opcions que encara estan per remetre resultats.<\/p>\n\n\n\n

Leuc\u00e8mia limfoc\u00edtica cr\u00f2nica<\/strong><\/h3>\n\n\n\n

El cap del Servei d\u2019Hematologia d\u2019Althaia, el Dr. Albert Alt\u00e9s<\/strong>, va abordar les opcions de tractament actuals i futures de la leuc\u00e8mia limfoc\u00edtica cr\u00f2nica<\/strong>, en la segona sessi\u00f3 del curs. El Dr. Alt\u00e9s va explicar que la incorporaci\u00f3 dels inhibidors de la tirosina de Bruton<\/strong> com l\u2019ibrutinib, l’acalabrutinib, en el futur zanubrutinib, aix\u00ed com el venetoclax i en combinacions sense citot\u00f2xics han canviat enormement el pron\u00f2stic <\/strong>i millorat la qualitat de vida dels pacients<\/strong>. En la sessi\u00f3, es va dir que els panells gen\u00e8tics<\/strong> seran una eina assistencial pr\u00f2xima per determinar el pron\u00f2stic i la predicci\u00f3 de resposta als tractaments.<\/p>\n\n\n\n

Mieloma m\u00faltiple<\/strong><\/h3>\n\n\n\n

En la tercera sessi\u00f3, el Dr. Albert Oriol Rocafiguera<\/strong>, cap de la Unitat d’Investigaci\u00f3 Cl\u00ednica de l\u2019ICO-Badalona de l’Hospital Universitari Germans Trias i Pujol, va fer un rep\u00e0s de la patologia (14% neoplasias) i les opcions de tractament actuals i futures. En aquest cas, l\u2019objectiu del tractament \u00e9s la curaci\u00f3<\/strong> i cada vegada s\u2019est\u00e0 m\u00e9s a prop amb les combinacions m\u00e9s noves, en lloc de la seq\u00fcenciaci\u00f3 cl\u00e0ssica. Les ter\u00e0pies cel\u00b7lulars amb CAR-T<\/strong> i anticossos biespec\u00edfics (BiTE) <\/strong>tenen tamb\u00e9 el seu paper en la malaltia molt refract\u00e0ria.<\/p>\n\n\n\n

Leuc\u00e8mia mieloide aguda<\/strong><\/h3>\n\n\n\n

Sobre la leuc\u00e8mia mieloide aguda<\/strong> en va parlar el cap del Servei d\u2019Hematologia de l\u2019Hospital Cl\u00ednic de Barcelona i investigador principal, el Dr. Jordi Esteve<\/strong>. En aquesta patologia, els determinants gen\u00e8tics s\u00f3n crucials pel pron\u00f2stic i maneig farmacol\u00f2gic<\/strong>. Els inhibidors de FLT3<\/strong> (midostaurin, gilteritinib), IDH<\/strong> (ivosidenib), Bcl-2<\/strong> i Plk<\/strong> s\u00f3n les principals novetats en el desenvolupament com a ter\u00e0pia dirigida. La immunoter\u00e0pia<\/strong> tamb\u00e9 t\u00e9 el seu paper en la malaltia refract\u00e0ria<\/strong>.<\/p>\n\n\n\n

El paper del farmac\u00e8utic\/a en els nous tractaments hematol\u00f2gics<\/strong><\/h2>\n\n\n\n

La quarta sessi\u00f3 va anar a c\u00e0rrec del farmac\u00e8utic adjunt de la Unitat de Pacients Externs del Servei de Farm\u00e0cia de l’ICO l\u2019Hospitalet de l\u2019Hospital Duran i Reynals, Eduard Fort<\/strong>. Segons el vocal d\u2019Hospitals del COFB, David Conde,<\/strong> el farmac\u00e8utic va revisar \u201cel paper del farmac\u00e8utic\/a envers els nous tractaments hematol\u00f2gics,<\/strong> ja que la gran majoria s\u00f3n orals<\/strong>“. <\/p>\n\n\n\n

\"Primera<\/a>
Primera fila, d\u2019esquerra a dreta: el Dr. Jordi Esteve i el farmac\u00e8utic Eduard Fort. Segona fila, d\u2019esquerra a dreta: la psic\u00f2loga Judit L\u00f3pez i el pacient que va oferir el seu testimoni.<\/figcaption><\/figure>\n\n\n\n

En la seva intervenci\u00f3 va destacar la import\u00e0ncia de dedicar temps en l\u2019educaci\u00f3 al pacient<\/strong> per prendre correctament la medicaci\u00f3, de revisar les interaccions amb la medicaci\u00f3 concomitant<\/strong> i medicina alternativa i de fer el seguiment d\u2019efectes secundaris<\/strong>. Des del punt de vista de Conde, “la comunicaci\u00f3<\/strong> amb tots els professionals sanitaris \u00e9s fonamental<\/strong>\u201d.<\/p>\n\n\n\n

La import\u00e0ncia del suport emocional en el tractament actiu<\/strong><\/h2>\n\n\n\n

El darrer dia del curs sobre l\u2019actualitzaci\u00f3 en oncologia hematol\u00f2gica es va dedicar a la import\u00e0ncia del suport emocional en el tractament actiu <\/strong>amb la psic\u00f2loga experta en ter\u00e0pia psicoemocional a pacients oncol\u00f2gics, Judit L\u00f3pez<\/strong>, i un pacient<\/strong>. El coordinador de les sessions, David Conde<\/strong>, va comentar posteriorment que \u201cel gui\u00f3 d\u2019aquesta sessi\u00f3 va ser constru\u00eft pels participants del curs, que van enviar pr\u00e8viament q\u00fcestions i dubtes sobre aquest tema. La psic\u00f2loga va ordenar les q\u00fcestions per oferir la seva visi\u00f3 sobre les situacions cr\u00edtiques <\/strong>que ens trobem en el nostre dia a dia i eines per afrontar-les<\/strong>\u201d. I va afegir que \u201cl\u2019abordatge emocional <\/strong>amb escolta activa i intentant acostar-se al pacient s\u00f3n crucials <\/strong>tamb\u00e9 per motivar al pacient <\/strong>a iniciar o seguir el tractament hemato-espec\u00edfic <\/strong>i crear confian\u00e7a amb el personal sanitari<\/strong>\u201d.<\/p>\n\n\n\n

Segons Conde, \u201cla sessi\u00f3 va ser completada amb el testimoni d\u2019un pacient <\/strong>en curs de tractament pel seu mieloma m\u00faltiple<\/strong> que va enriquir i tancar el cicle d\u2019aquestes sessions. Tot gira entorn del pacient i en aquesta ocasi\u00f3 li vam donar veu i va explicar la seva experi\u00e8ncia <\/strong>des del diagn\u00f2stic fins al dia d’avui\u201d.<\/p>\n\n\n\n

<\/p>\n\n\n

\n\n\n

Valoraci\u00f3 de David Conde, vocal d\u2019Hospitals del COFB<\/strong><\/h2>\n\n\n\n

El vocal d’Hospitals dels COFB, David Conde<\/strong>, va valorar molt positivament el curs, destacant l’\u00e8xit d’assist\u00e8ncia amb 100 farmac\u00e8utics i farmac\u00e8utiques inscrites<\/strong>. “L’objectiu a assolir era repassar els esquemes de tractament <\/strong>recomanats en patologies hematol\u00f2giques d’avui en dia <\/strong>com s\u00f3n la leuc\u00e8mia limfoc\u00edtica cr\u00f2nica, el limfoma del mantell, la malaltia de Waldesstr\u00f6m, el mieloma m\u00faltiple i la leuc\u00e8mia mieloide aguda”, va comentar Conde.<\/p>\n\n\n\n

“En aquestes patologies hem tingut aven\u00e7os molt importants <\/strong>en els darrers temps que fan necess\u00e0ria l’actualitzaci\u00f3 que hem gaudit per part de ponents experts en cada una de les malalties, que a m\u00e9s ens han fet un tastet de les futures ter\u00e0pies prometedores<\/strong>“, va afegir el vocal d’Hospitals del COFB.<\/p>\n\n\n\n

\"David<\/a>
David Conde en un moment del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d.<\/figcaption><\/figure>\n\n\n\n

“Es van realitzar dues sessions sobre suport emocional<\/strong> i el paper del farmac\u00e8utic cl\u00ednic <\/strong>envers aquests tractaments. Com que la majoria de tractaments s\u00f3n orals \u00e9s rellevant connectar emocionalment <\/strong>amb els pacients<\/strong> i una bona educaci\u00f3 <\/strong>per part de la farm\u00e0cia <\/strong>per complir els objectius terap\u00e8utics<\/strong>“, va assenyalar Conde.<\/p>\n\n\n\n

Finalment, el vocal va destacar que “la novetat dins de la sessi\u00f3 d’abordatge emocional va ser que vam comptar amb la pres\u00e8ncia d’un pacient en curs <\/strong>de tractament pel seu mieloma m\u00faltiple <\/strong>que va enriquir i tancar el cicle d’aquestes sessions\u201d.<\/p><\/div>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n
\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), va organitzar una noa edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d, amb el patrocini de Bristol-Myers Squibb i Janssen. L\u2019activitat va constar de cinc sessions que van realitzar experts de refer\u00e8ncia en cadascun dels […]<\/p>\n","protected":false},"author":1,"featured_media":67786,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[467,723,1037,18,19,53,1038,122,70,1039,1040,1041,1042,1043,1044,1045,724,1046,1047,286,129,1048,63,1049],"class_list":["post-65693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-activitats-formatives","tag-cancer","tag-cancer-hematologic","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmaceutics-hospital","tag-farmaceutics-hospitalaris","tag-formacio","tag-leucemia","tag-leucemia-limfocitica-cronica","tag-leucemia-mieloide-aguda","tag-limfoma-cellules-mantell","tag-malaltia-de-waldenstrom","tag-mieloma","tag-mieloma-multiple","tag-oncologia","tag-oncologia-hematologica","tag-patologia-hematologica","tag-societat-catalana-de-farmacia-clinica","tag-societat-catalana-de-farmacia-clinica-scfc","tag-suport-emocional","tag-tractament","tag-tractament-hematologic"],"yoast_head":"\nNova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-30T09:39:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-09T10:47:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d\",\"datePublished\":\"2022-12-30T09:39:21+00:00\",\"dateModified\":\"2023-10-09T10:47:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\"},\"wordCount\":1421,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png\",\"keywords\":[\"activitats formatives\",\"c\u00e0ncer\",\"c\u00e0ncer hematol\u00f2gic\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"farmac\u00e8utics hospital\",\"farmac\u00e8utics hospitalaris\",\"Formaci\u00f3\",\"Leuc\u00e8mia\",\"Leuc\u00e8mia limfoc\u00edtica cr\u00f2nica\",\"leuc\u00e8mia mieloide aguda\",\"limfoma c\u00e8l\u00b7lules mantell\",\"malaltia de Waldenstr\u00f6m\",\"mieloma\",\"mieloma m\u00faltiple\",\"oncologia\",\"oncologia hematol\u00f2gica\",\"patologia hematol\u00f2gica\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)\",\"suport emocional\",\"tractament\",\"tractament hematol\u00f2gic\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\",\"name\":\"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png\",\"datePublished\":\"2022-12-30T09:39:21+00:00\",\"dateModified\":\"2023-10-09T10:47:36+00:00\",\"description\":\"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/","og_locale":"ca_ES","og_type":"article","og_title":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.","og_url":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-12-30T09:39:21+00:00","article_modified_time":"2023-10-09T10:47:36+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png","type":"image\/png"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d","datePublished":"2022-12-30T09:39:21+00:00","dateModified":"2023-10-09T10:47:36+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/"},"wordCount":1421,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png","keywords":["activitats formatives","c\u00e0ncer","c\u00e0ncer hematol\u00f2gic","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","farmac\u00e8utics hospital","farmac\u00e8utics hospitalaris","Formaci\u00f3","Leuc\u00e8mia","Leuc\u00e8mia limfoc\u00edtica cr\u00f2nica","leuc\u00e8mia mieloide aguda","limfoma c\u00e8l\u00b7lules mantell","malaltia de Waldenstr\u00f6m","mieloma","mieloma m\u00faltiple","oncologia","oncologia hematol\u00f2gica","patologia hematol\u00f2gica","Societat Catalana de Farm\u00e0cia Cl\u00ednica","Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)","suport emocional","tractament","tractament hematol\u00f2gic"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/","url":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/","name":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png","datePublished":"2022-12-30T09:39:21+00:00","dateModified":"2023-10-09T10:47:36+00:00","description":"El COFB, juntament amb la SCFC, va organitzar la segona edici\u00f3 del curs d'actualitzaci\u00f3 en en oncologia hematol\u00f2gica.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/30\/nova-edicio-del-curs-actualitzacio-en-oncologia-hematologica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nova edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png",1024,683,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1-150x150.png",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1-300x200.png",300,200,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1-768x512.png",768,512,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png",1024,683,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png",1024,683,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png",1024,683,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_ONCOLOGIA-HEMATOLOGICA_22122022_1-1024x683-1.png",18,12,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), va organitzar una noa edici\u00f3 del curs \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d, amb el patrocini de Bristol-Myers Squibb i Janssen. L\u2019activitat va constar de cinc sessions que van realitzar experts de refer\u00e8ncia en cadascun dels […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/65693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=65693"}],"version-history":[{"count":3,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/65693\/revisions"}],"predecessor-version":[{"id":68972,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/65693\/revisions\/68972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67786"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=65693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=65693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=65693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}